[HTML][HTML] The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low-and middle-income countries: A systematic review and meta …
Background Bloodstream infections (BSIs) produced by antibiotic-resistant bacteria (ARB)
cause a substantial disease burden worldwide. However, most estimates come from high …
cause a substantial disease burden worldwide. However, most estimates come from high …
[HTML][HTML] Antimicrobial susceptibility of bacterial isolates from clinical specimens in four Pacific Island countries, 2017–2021
MJ Loftus, RJ Everts, AC Cheng, P Eti… - The Lancet Regional …, 2023 - thelancet.com
Background There are limited antimicrobial resistance (AMR) surveillance data from low-
and middle-income countries, especially from the Pacific Islands region. AMR surveillance …
and middle-income countries, especially from the Pacific Islands region. AMR surveillance …
[HTML][HTML] Molecular and clinical epidemiology of carbapenem resistant Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacterales in Fiji: a multicentre …
SC Baleivanualala, S Matanitobua, V Soqo… - The Lancet Regional …, 2024 - thelancet.com
Summary Background Carbapenem resistant organisms (CROs) such as Acinetobacter
baumannii (CRAb), Pseudomonas aeruginosa (CRPa), Escherichia coli (CREc), and …
baumannii (CRAb), Pseudomonas aeruginosa (CRPa), Escherichia coli (CREc), and …
Local and timely antimicrobial resistance data for local and national actions: the early implementation of an automated tool for data analysis at local hospital level in …
V Srisuphan, P Klaytong… - JAC-Antimicrobial …, 2023 - academic.oup.com
Background In low-and middle-income countries (LMICs), hospitals can rarely utilize their
own antimicrobial resistance (AMR) data in a timely manner. Objectives To evaluate the …
own antimicrobial resistance (AMR) data in a timely manner. Objectives To evaluate the …
[引用][C] JAC-Antimicrobial Resistance
V Srisuphan, P Klaytong, C Rangsiwutisak… - 2023 - europepmc.org
Background: In low-and middle-income countries (LMICs), hospitals can rarely utilize their
own antimicrobial resistance (AMR) data in a timely manner. Objectives: To evaluate the …
own antimicrobial resistance (AMR) data in a timely manner. Objectives: To evaluate the …